Data security software provider CybelAngel has now accumulated $52m in funding altogether, with CNP Assurances' Open CNP unit backing its latest round.

Biopsy verification technology developer Strand Diagnostics had raised $7.5m of a commitment from Nantworks originally slated to reach $30m.

Parimal Nathwani has been promoted to president and CEO of Toronto Innovation Acceleration Partners, as GUV Powerlist awardee Raphael Hofstein retires.

Frog will take equity in future Tuesday Capital portfolio companies in return for providing design services, building on an existing partnership between the pair.

D1 Capital Partners has led a series E round for Outset Medical, pushing the OSU dialysis device spinout’s overall funding to more than $430m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Strategic partner CJ Entertainment and Merchandising and existing backer Tencent invested in a round that reportedly valued the entertainment studio at $2.3bn.

The genomic drug developer, spun out of Harvard University, has completed its initial public offering, boosting its size from $180m to $207m.

The genomic drug developer, which counts GV as an investor, has completed its initial public offering, boosting its size from $180m to $207m.

Infosys has agreed to pay $250m for sales services provider Simplus, which had raised more than $40m in funding from backers including Salesforce Ventures.